Proglycem
NDC 0575-6200, diazoxide, suspension, from Teva Pharmaceuticals USA, Inc..
- Product NDC
- 0575-6200
- Status
- Listed
- Labeler
- Teva Pharmaceuticals USA, Inc.
- Dosage form
- SUSPENSION
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA
- Application
- NDA017453
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/0575-6200 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- DIAZOXIDE50 mg/mL
| Package NDC | NDC-11 | Package |
|---|---|---|
| 0575-6200-30 | 00575620030 | 1 BOTTLE, DROPPER in 1 BOX (0575-6200-30) / 30 mL in 1 BOTTLE, DROPPER |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/b16c7832-2fd9-49af-b923-1dc0d91fd6e2NADAC price for package 00575620030
GET /v1/drugs/nadac/00575620030
Use it
Look up 0575-6200 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/0575-6200 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 0575-6200. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.